Results of the 2nd comparative study have been documented by Flinn et al. It is a section III randomized Intergroup trial evaluating FC regimen compared to FAMP by itself in 278 sufferers acquiring their very first chemotherapy routine for B-CLL. Dosages of FC schedule had been the same as the https://cf5302468.mpeblog.com/53754480/the-basic-principles-of-colistimethate-sodium